A Study to Evaluate the Effect of Two Different Repeat Doses of GSK2190915 on the QTc Interval.

This study has suspended participant recruitment.

(Study was put on hold prior to dosing)

Sponsor:

Information provided by (Responsible Party):

GlaxoSmithKline

ClinicalTrials.gov Identifier:

NCT01721135

First received: November 1, 2012

Last updated: NA

Last verified: November 2012

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has suspended participant recruitment.
Estimated Study Completion Date:	December 2014
Estimated Primary Completion Date:	December 2014 (Final data collection date for primary outcome measure)